FDA NDC Directory · JSON-LD · Markdown

Spironolactone and Hydrochlorothiazide

NDC 0378-0403 · HUMAN PRESCRIPTION DRUG · TABLET

Generic namespironolactone and hydrochlorothiazide
Labeler / ManufacturerMylan Pharmaceuticals Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA086513
Dosage form / routeTABLET · ORAL
Active ingredientsHYDROCHLOROTHIAZIDE (25 mg/1)
SPIRONOLACTONE (25 mg/1)
Marketing started19790803
Package count2

External sources

Source: openFDA. Public-domain (CC0).